ABSTRACT
INTRODUCTION This review of the use of CpG oligodeoxynucleotide (ODN) agonists to toll-like receptor (TLR)9 as vaccine adjuvants briefly covers immune effects and mechanisms of CpG ODN and then provides more details as to how they can be used to enhance prophylactic and therapeutic vaccines against human or veterinary infectious diseases, cancer, and allergies.
